These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 35604094)

  • 21. Generation of Bioactivity-Tailored FK506/FK520 Analogs by CRISPR Editing in Streptomyces tsukubaensis.
    Buntin K; Mrak P; Pivk Lukančič P; Wollbrett S; Drčar T; Krastel P; Thibaut C; Salcius M; Gao X; Wang S; Weber E; Koplan E; Regenass H
    Chemistry; 2024 Jan; 30(3):e202302350. PubMed ID: 37855054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FK506-binding protein (FKBP12) regulates ryanodine receptor-evoked Ca2+ release in colonic but not aortic smooth muscle.
    MacMillan D; Currie S; McCarron JG
    Cell Calcium; 2008 Jun; 43(6):539-49. PubMed ID: 17950843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapamycin exerts antifungal activity in vitro and in vivo against Mucor circinelloides via FKBP12-dependent inhibition of Tor.
    Bastidas RJ; Shertz CA; Lee SC; Heitman J; Cardenas ME
    Eukaryot Cell; 2012 Mar; 11(3):270-81. PubMed ID: 22210828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcineurin is required for virulence of Cryptococcus neoformans.
    Odom A; Muir S; Lim E; Toffaletti DL; Perfect J; Heitman J
    EMBO J; 1997 May; 16(10):2576-89. PubMed ID: 9184205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms.
    Uppuluri P; Nett J; Heitman J; Andes D
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1127-32. PubMed ID: 18180354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapamycin antifungal action is mediated via conserved complexes with FKBP12 and TOR kinase homologs in Cryptococcus neoformans.
    Cruz MC; Cavallo LM; Görlach JM; Cox G; Perfect JR; Cardenas ME; Heitman J
    Mol Cell Biol; 1999 Jun; 19(6):4101-12. PubMed ID: 10330150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of calcineurin inhibitors, cyclosporine A and tacrolimus (FK506), on the activity of antifungal drugs against
    Şen Kaya S; Kiraz N; Bariş A; Turan D; Öz Y; Dağ İ; Aygün G
    J Med Microbiol; 2021 Apr; 70(4):. PubMed ID: 33915075
    [No Abstract]   [Full Text] [Related]  

  • 28. Good fungi gone bad: the corruption of calcineurin.
    Fox DS; Heitman J
    Bioessays; 2002 Oct; 24(10):894-903. PubMed ID: 12325122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions of FK506 and Rapamycin With FK506 Binding Protein 12 in Opportunistic Human Fungal Pathogens.
    Vellanki S; Garcia AE; Lee SC
    Front Mol Biosci; 2020; 7():588913. PubMed ID: 33195437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structures of Pathogenic Fungal FKBP12s Reveal Possible Self-Catalysis Function.
    Tonthat NK; Juvvadi PR; Zhang H; Lee SC; Venters R; Spicer L; Steinbach WJ; Heitman J; Schumacher MA
    mBio; 2016 Apr; 7(2):e00492-16. PubMed ID: 27118592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcineurin is essential for survival during membrane stress in Candida albicans.
    Cruz MC; Goldstein AL; Blankenship JR; Del Poeta M; Davis D; Cardenas ME; Perfect JR; McCusker JH; Heitman J
    EMBO J; 2002 Feb; 21(4):546-59. PubMed ID: 11847103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcineurin Inhibitor CN585 Exhibits Off-Target Effects in the Human Fungal Pathogen
    Juvvadi PR; Bobay BG; Cole DC; Awwa M; Steinbach WJ
    J Fungi (Basel); 2022 Dec; 8(12):. PubMed ID: 36547614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cryptococcus neoformans isolates from transplant recipients are not selected for resistance to calcineurin inhibitors by current immunosuppressive regimens.
    Blankenship JR; Singh N; Alexander BD; Heitman J
    J Clin Microbiol; 2005 Jan; 43(1):464-7. PubMed ID: 15635017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling the interaction between FK506 and FKBP12: a mechanism for formation of the calcineurin inhibitory complex.
    Ivery MT; Weiler L
    Bioorg Med Chem; 1997 Feb; 5(2):217-32. PubMed ID: 9061187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunosuppressive and nonimmunosuppressive cyclosporine analogs are toxic to the opportunistic fungal pathogen Cryptococcus neoformans via cyclophilin-dependent inhibition of calcineurin.
    Cruz MC; Del Poeta M; Wang P; Wenger R; Zenke G; Quesniaux VF; Movva NR; Perfect JR; Cardenas ME; Heitman J
    Antimicrob Agents Chemother; 2000 Jan; 44(1):143-9. PubMed ID: 10602736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Novel Resistance Pathway for Calcineurin Inhibitors in the Human-Pathogenic Mucorales Mucor circinelloides.
    Vellanki S; Billmyre RB; Lorenzen A; Campbell M; Turner B; Huh EY; Heitman J; Lee SC
    mBio; 2020 Jan; 11(1):. PubMed ID: 31992620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative analysis of calcineurin inhibition by complexes of immunosuppressive drugs with human FK506 binding proteins.
    Weiwad M; Edlich F; Kilka S; Erdmann F; Jarczowski F; Dorn M; Moutty MC; Fischer G
    Biochemistry; 2006 Dec; 45(51):15776-84. PubMed ID: 17176100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium- and FK506-independent interaction between the immunophilin FKBP51 and calcineurin.
    Li TK; Baksh S; Cristillo AD; Bierer BE
    J Cell Biochem; 2002; 84(3):460-71. PubMed ID: 11813252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new and clinically relevant murine model of solid-organ transplant aspergillosis.
    Herbst S; Shah A; Carby M; Chusney G; Kikkeri N; Dorling A; Bignell E; Shaunak S; Armstrong-James D
    Dis Model Mech; 2013 May; 6(3):643-51. PubMed ID: 23264562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FK506, an immunosuppressant targeting calcineurin function.
    Dumont FJ
    Curr Med Chem; 2000 Jul; 7(7):731-48. PubMed ID: 10702636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.